Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis. 2012

Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.

Sphingosine 1-phosphate (S1P)/S1P receptor 1 (S1P1) signaling plays an important role in synovial cell proliferation and inflammatory gene expression by rheumatoid arthritis (RA) synoviocytes. The purpose of this study is to clarify the role of S1P/S1P1 signaling in the expression of receptor activator of NF-κB ligand (RANKL) in RA synoviocytes and CD4(+) T cells. We demonstrated MH7A cells, a human RA synovial cell line, and CD4(+) T cells expressed S1P1 and RANKL. Surprisingly, S1P increased RANKL expression in MH7A cells and CD4(+) T cells in a dose-dependent manner. Moreover, S1P enhanced RANKL expression induced by stimulation with TNF-α in MH7A cells and CD4(+) T cells. These effects of S1P in MH7A cells were inhibited by pretreatment with PTX, a specific Gi/Go inhibitor. These findings suggest that S1P/S1P1 signaling may play an important role in RANKL expression by MH7A cells and CD4(+) T cells. S1P/S1P1 signaling of RA synoviocytes is closely connected with synovial hyperplasia, inflammation, and RANKL-induced osteoclastogenesis in RA. Thus, regulation of S1P/S1P1 signaling may become a novel therapeutic target for RA.

UI MeSH Term Description Entries
D008246 Lysophospholipids Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal. Lysophosphatidic Acids,Lysophospholipid,Acids, Lysophosphatidic
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013110 Sphingosine An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed) 4-Sphingenine,4 Sphingenine
D013582 Synovial Fluid The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints. Synovia,Fluid, Synovial,Fluids, Synovial,Synovial Fluids
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D049349 Receptors, Lysosphingolipid A subfamily of lysophospholipid receptors with specificity for LYSOSPHINGOLIPIDS such as sphingosine-1-phosphate and sphingosine phosphorylcholine. Lysosphingolipid Receptors,Lysosphingolipid Receptor,Receptor, Lysosphingolipid

Related Publications

Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
February 2024, Veterinary immunology and immunopathology,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
January 2018, Methods in molecular biology (Clifton, N.J.),
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
October 2012, In vitro cellular & developmental biology. Animal,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
November 2019, International journal of molecular sciences,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
March 2006, Arthritis and rheumatism,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
September 2017, Oncotarget,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
July 2014, Cellular signalling,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
January 2016, Molecular and cellular biology,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
January 2023, Brain research,
Harunori Takeshita, and Masayasu Kitano, and Tsuyoshi Iwasaki, and Sachie Kitano, and Sachi Tsunemi, and Chieri Sato, and Masahiro Sekiguchi, and Naoto Azuma, and Keiji Miyazawa, and Timothy Hla, and Hajime Sano
February 2011, Neurology,
Copied contents to your clipboard!